732 related articles for article (PubMed ID: 24183448)
1. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.
Davoli T; Xu AW; Mengwasser KE; Sack LM; Yoon JC; Park PJ; Elledge SJ
Cell; 2013 Nov; 155(4):948-62. PubMed ID: 24183448
[TBL] [Abstract][Full Text] [Related]
2. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
3. SWAN pathway-network identification of common aneuploidy-based oncogenic drivers.
Bowers RR; Jones CM; Paz EA; Barrows JK; Armeson KE; Long DT; Delaney JR
Nucleic Acids Res; 2022 Apr; 50(7):3673-3692. PubMed ID: 35380699
[TBL] [Abstract][Full Text] [Related]
4. [Oncogenes, tumor suppressor genes, and aneuploidy: the sum of the nuances].
Blay JY
Bull Cancer; 2014 Apr; 101(4):340. PubMed ID: 24918235
[No Abstract] [Full Text] [Related]
5. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Gnad F; Doll S; Manning G; Arnott D; Zhang Z
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S5. PubMed ID: 26110843
[TBL] [Abstract][Full Text] [Related]
8. Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers.
Park S; Supek F; Lehner B
Nat Commun; 2021 Dec; 12(1):7051. PubMed ID: 34862370
[TBL] [Abstract][Full Text] [Related]
9. Cancer aneuploidies are shaped primarily by effects on tumour fitness.
Shih J; Sarmashghi S; Zhakula-Kostadinova N; Zhang S; Georgis Y; Hoyt SH; Cuoco MS; Gao GF; Spurr LF; Berger AC; Ha G; Rendo V; Shen H; Meyerson M; Cherniack AD; Taylor AM; Beroukhim R
Nature; 2023 Jul; 619(7971):793-800. PubMed ID: 37380777
[TBL] [Abstract][Full Text] [Related]
10. Extensive protein dosage compensation in aneuploid human cancers.
Schukken KM; Sheltzer JM
Genome Res; 2022 Jul; 32(7):1254-1270. PubMed ID: 35701073
[TBL] [Abstract][Full Text] [Related]
11. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
[TBL] [Abstract][Full Text] [Related]
12. On the karyotypic origin and evolution of cancer cells.
Nicholson JM; Duesberg P
Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes.
Zhang Y; Xia J; Zhang Y; Qin Y; Yang D; Qi L; Zhao W; Wang C; Guo Z
PLoS One; 2013; 8(3):e58163. PubMed ID: 23472150
[TBL] [Abstract][Full Text] [Related]
15. Recurrent hemizygous deletions in cancers may optimize proliferative potential.
Solimini NL; Xu Q; Mermel CH; Liang AC; Schlabach MR; Luo J; Burrows AE; Anselmo AN; Bredemeyer AL; Li MZ; Beroukhim R; Meyerson M; Elledge SJ
Science; 2012 Jul; 337(6090):104-9. PubMed ID: 22628553
[TBL] [Abstract][Full Text] [Related]
16. Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns.
Sack LM; Davoli T; Li MZ; Li Y; Xu Q; Naxerova K; Wooten EC; Bernardi RJ; Martin TD; Chen T; Leng Y; Liang AC; Scorsone KA; Westbrook TF; Wong KK; Elledge SJ
Cell; 2018 Apr; 173(2):499-514.e23. PubMed ID: 29576454
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of microRNA Binding Site Distribution and microRNA-Mediated Gene Expression Repression of Oncogenes and Tumor Suppressor Genes.
Tian S; Wang J; Zhang F; Wang D
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328035
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors.
Giefing M; Wierzbicka M; Rydzanicz M; Cegla R; Kujawski M; Szyfter K
Neoplasma; 2008; 55(1):55-60. PubMed ID: 18190242
[TBL] [Abstract][Full Text] [Related]
20. Cell competition removes segmental aneuploid cells from
Ji Z; Chuen J; Kiparaki M; Baker N
Elife; 2021 Apr; 10():. PubMed ID: 33847264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
